NeilPetry

Pharmacist • Durham, NC

Associate Professor of Radiology, Medical Physics Program Faculty and Director, Radiopharmacy Services

Join to view full profile

Neil Petry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Neil Petry's full profile

Already have an account?

Summary

Dr. Neil Petry is a pharmacist and nuclear pharmacy expert in Durham, NC. He is experienced in stroke, computed tomography, molecular imaging and therapy (radiotheranostics). He has more than 100 publications.

Certifications & Licensure

Board of Pharmacy Specialties (BPS) Nuclear Pharmacy

Education & Training

Purdue University College of PharmacyM.S., Nuclear Pharmacy, Rho Chi, 1977
Purdue University, Department of BionucleonicsM.S., Nuclear Pharmacy, 1977
Purdue University, School of Pharmacy and Pharmaceutical SciencesB.S., Pharmacy, 1975

Awards, Honors, & Recognition

Sally W. Schwarz Award for Outstanding Contribution in Radiopharmacy Society of Nuclear Medicine and Molecular Imaging, 2022
William H. Briner Distinguished Achievement Award Academy of Pharmacy Practice and Management, American Pharmacists Association, 2009
Fellow Leonard Davis Institute of Health Economics, The Wharton School, University of Pennsylvania, GlaxoSmithKline Executive Management Program for Pharmacy Leaders, 2000
Fellow of the American Pharmacists Association (FAPhA) 1998
Distinguished Achievement Award Division of Nuclear Medicine, University of Michigan, 1998
Rho Chi Society (Pharmacy Honorary) 1977
Join now to see all

Publications & Presentations

Journal Articles

Predictors of survival in 211 patients with stage IV pulmonary and gastroenteropancreatic mIBG positive neuroendocrine tumors treated with I-131 mIBG
Kane A., Thorpe M.P., Morse M.A., Howard B.A., Oldan J.D., Zhu J., Wong T., Petry N.A., Reiman R., and Borges-Neto S., J. Nucl. Med., 1/18/2018
Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats
Bao X., Chandramohan V., Reynolds, R.P., Norton J.N., Wetsel W.C., Rodriguiz R.M., Aryal D.K., McLendon R.E., Levin E.D., Petry N.A., Zalutsky M.R., Burnett B.K., Kuan..., Invest. New Drugs, 1/1/2016
Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123I-Iobenguane
Chin B.B., Kronauge J.F., Femia F.J., Chen J., Maresca, K.P., Hillier S., Petry N.A., James O.G., Oldan J.D., Armor T., Stubbs J.B., Stabin M.G., Babich J.W., J. Nucl. Med., 1/1/2014
Direct in vivo evidence of activated macrophages in human osteoarthritis
Kraus, V.B., McDaniel, G., Huebner, J.L., Pieper, C., Coleman, R.E., Petry, N.A., Low, P.S., Shen J., and Mitchell, P., Osteoarthritis and Cartilage, 1/1/2013
The future of USP monographs for PET drugs
Schwarz S., Norenberg J., Berridge, M., Dragotakes S., Hung J., Link J., Mason N.S., Mattmuller S., Nickel R.A., Packard A., Paolino J., Petry N.A., Ponto J.A., Quinto..., J. Nucl. Med., 1/1/2013
First-in man evaluation of two high-affinity PSMA-avid small molecules for imaging prostate cancer
Barrett J.A., Coleman R.E., Goldsmith S.J., Vallabhajosula S., Petry N.A., Cho S., Armor T., Stubbs J.B., Maresca K.P., Stabin M.G., Joyal J.L., Eckleman W.C. and Babi..., J. Nucl. Med., 1/1/2013
Sincalide is temporarily unavailable -again
Ziessman H., Petry N.A., J. Nucl. Med., 1/1/2013
Prescriber Beware - It Is Ill Advised To Administer Compounded Sincalide
Norenberg J.P., Ponto J.A., Petry N.A., Wittstrom, K.M., J. Nucl. Med., 1/1/2013
Alumina depyrogenates F 18 fludeoxyglucose injection during purification processes
Cooper J.F., Petry N.A., Engelbrecht H., and Breslow K., PDA J. Pharm. Sci. Technol., 1/1/2012
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans
Sampson J.H., Brady M., Raghavan R., Mehta A.I., Reardon D.A., Petry N.A., Barboriak D. P., Wong T.Z., Zalutsky M.R., Lally-Goss D., Bigner D.D., Neurosurgery, 1/1/2011
Operation of a radiopharmacy for a clinical trial
Norenberg J.P., Petry N.A., and Schwarz S., Semin. Nucl. Med., 1/1/2010
A novel infusion method for therapeutic radiopharmaceuticals
Yokell D., Dragotakes S., Gallagher P., de la Guardia M., Kronauge J., Norenberg J., Petry N., Ponto J., and Babich J., J Nucl Med, 1/1/2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
Sampson J.H., Akabani G., Archer G.E., Berger M.S., Coleman R.E., Friedman A.H., Friedman H.S., Greer K., Herndon J.E., Kunwar S., McLendon R.E., Paolino A., Petry N.A..., Neuro. Oncol., 1/1/2008
A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States
Shultz M.K., Cessna J.T., Anderson T.L., Ponto J.A., Petry N., Kowalsky R.J., Palmer M.R., Beinlich U.F., Baker W., Hinkle G.H., Hung J.C., Quinton T., Rice P.A., Divg..., Appl. Radiat. Isot., 1/1/2008
PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu Generator
Wong T.Z., Yuan H. Vlahovic G, Petry N.A., Lacy J.L., Hawk T.C., and Dewhirst M.W., AJR Am. J. Roentgenol., 1/1/2008
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning
Sampson J.H., Brady M.L., Petry N.A., Croteau D., Friedman A.H., Friedman H.S., Wong T., Bigner D.D., Pastan I., Puri R.K., Pedain C., Neurosurgery, 1/1/2007
Left ventricular functional assessment in mice: feasibility of high spatial and temporal resolution ECG-gated blood pool SPECT
Chin B.B., Metzler S.D., Lemaire A., Curcio A., Vemulapalli S., Greer K.L., Petry N.A., Turkington T.G., Coleman R.E., Rockman H., Jaszczak R.J., Radiology, 1/1/2007
Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT
Vemulapalli, S., Metzler S.D., Akabani, G., Petry, N.A., Niehaus N.J., Liu X., Patil N., Greer, K.L., Jaszczak, R.J., Coleman, R.E., Dong, C., Goldschmidt-Clermont P.J..., Radiology, 1/1/2007
A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation
Kleiter M.M., Yu D., Mohammadian L.A., Niehaus N., Spasojevic I., Sanders L., Viglianti B.L., Yarmelenko P.S., Hauck M., Petry N.A., Wong T.Z., Dewhirst M.W., and Thar..., Clin. Cancer Res., 1/15/2006
In vivo ultrahigh resolution ECG gated pinhole 99mTc tetrofosmin SPECT of myocardial function in transaortic constriction murine model of heart failure
Chin, B.B., Metzler, S.D., Perrino, C., Mao, L., Petry, N., Niehaus, N., Greer, K., Jaszczak, R.J., and Rockman, H., Mol Imaging Biol, 1/1/2006
Ultrahigh spatial and temporal resolution ECG gated blood pool micro-SPECT imaging of murine myocardial function
Chin, B.B., Metzler, S.D., Mao, L., Petry, N., Neihaus, N., Greer, K., Turkington, T., Coleman, R.E., Jaszczak, R.J., and Rockman, H., J Nucl Med, 1/1/2006
In vivo murine 99mTc red blood cell labeling methods for cardiac function and vascular blood pool localization
Vemulapalli S, Metzler SD, Petry N, et al, Mol Imaging Biol, 1/1/2005
In vivo bone marrow cell trafficking in mice with 111Indium-oxine radiolabeling and helical pinhole SPECT
Vemulapalli, S., Metzler, S.D., Akabani, G., Petry, N., Niehaus, N.J., Liu X., Patil, N.H., Greer, K.L., Jaszczak, R.J., Coleman, R.E., Dong, C., Goldschmidt-Clermont,..., J Nucl Med, Society of Nuclear Medicine, 1/1/2004
Evaluation of CYP3A4 metabolic phenotype and cyclophosphamide pharmacokinetics in patients receiving high-dose therapy
Petros, W., Vredenburgh, J., Fehdrau, R., Chao, N., Broadwater, G., Fangmeier, J., Petry, N., Coleman, R.E., and Colvin, M., Proceedings of the American Association for Cancer Research, 1/1/2002
Comprehensive review and revision of thyroid bioassay procedures in radionuclide therapy using iodine 131
Yoshizumi, T.T., Reiman, R.E., Sarder, M.R., Coleman, R.E., Petry, N.A., and Schuler, F.R., Health Physics, 1/1/2002
Join now to see all

Books/Book Chapters

Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine
Chapter: Licensing and regulatory control.
Page 157 - 211Petry, N.A.Editors: R. J. Kowalsky and S.W. Falen.American Pharmacists Association, Washington, DCEdition 2nd,2004
Pharmaceuticals in Medical Imaging
Chapter: Radiopharmaceuticals for the endocrine imaging: IV. Adrenalmedullary imaging.
Page 369 - 393Petry, N.A. and Shapiro, B.Editors: D.P. Swanson, H.M. Chilton, and J.H. Thrall.Macmillan Publishing Co., Inc., New York1990
Emission Computed Tomography: Current Trends
Chapter: Collimation for I-123 imaging with SPECT.
Page 135 - 145Coleman, R.E., Greer, K.L., Drayer, B.P., Albright, R.E., Petry, N.A. and Jaszczak, R.J.Editors: P.D. Esser.Society of Nuclear Medicine, Inc., New York, NY1983
Nuclear Radiology (Third Series Syllabus)
Petry, N.A.Editors: E.G. Theros and J.H. Harris, Jr..American College of Radiology, Chicago, IL1983
Functional Radionuclide Imaging of the Brain
Chapter: In Vivo quantitation of regional cerebral blood flow: The SPECT-HIPD method.
Page 193 - 207Petry, N. and Coleman, R.E.Editors: P.L. Megistretti.Raven Press, New York, NY1983
Join now to see all

Abstracts/Posters

Technologist radiation exposure and patient safety improved with automated FDG dosage preparation and injection system.
Seibert J.A., Nguyen G., Yoshizumi T.T., and Petry N.A., Society of Nuclear Medicine and Molecular Imaging (SNMMI) Meeting, St. Louis, MO, 1/7/2014
Phase 1 clinical trial results for high specific activity Ultratrace Iobenguane I 123.
Chin, B., Grasfeder, L., Femia, F., Hillier, S., Petry, N., Armor, T., Stubbs, J., Stabin, M., Babich, J., and Kronauge, J., Society of Nuclear Medicine and Molecular Imaging (SNMMI) Meeting, Miami, FL, 1/9/2012
Endotoxin pyrogen removal by alumina in PET synthesis units.
Petry N.A., Engelbrecht H., Breslow K., and Cooper J.F., Society of Nuclear Medicine (SNM) Meeting, Miami, FL, 1/9/2012
Formulation and human distribution comparison of AdreView and Ultratrace Iobenguane I 123.
Chin B.B., Grasfeder L.L., Chen J., Femia F.J., Luss E., Barrett J.A., Petry N.A., Greer K.L., Babich J.W., and Kronauge J.F., Society of Nuclear Medicine (SNM) Meeting, San Antonio, TX, 1/4/2011
Targeting metastatic prostate cancer (PCa) in patients with 123I-MIP1072 & 123I-MIP1095.
Barrett J.A., LaFrance N., Coleman R.R., Goldsmith S. Stubbs J., Petry N.A., Vallabhajosula S., Maresca K., Femia F., Babich J., Society of Nuclear Medicine (SNM) Meeting, Toronto, Canada, 1/13/2009
Aerosolized amphotericin B lipid complex (aABLC) distribution in lung transplant recipients: A comparison of continuous versus breath actuated nebulizers.
Dodds E.S., Petry N.A., Davies J.A., Zaas D.A., Palmer S.M., Shipes S.W., Drew R.H., Alexander B.D., Coleman R.E., and Perfect J.R., Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Meeting, Chicago, IL, 1/17/2007
Radiation dosimetry and clearance of no carrier added 131I-MIBG (UltratraceTM Iobenguane I 131) in 7 carcinoid and 4 pheochromocytoma patients.
Barrett J.A., Coleman R.E., Morse M.A., Borys N., Kronauge J.F., Stubbs J.B., Mok H., Qi J., Petry N., Vaidyanathan G. and Babich J.W., European Association of Nuclear Medicine (EANM) Meeting, Copenhagen, Denmark, 1/13/2007
Prognosis in stroke using the comparison of CT and 99m Tc-HM-PAO SPECT.
Mountz J.M., Modell J.G., Foster N.L., DuPree E.S., Ackermann R.J., Petry N.A., Bluemlein L.E., Kuhl D.E., Brain 87 XIVth International - Meeting on Cerebral Flow and Metabolism, Bologna, Italy, 1/28/1989
Kinetics of the new Tc-99m labeled blood flow marker (SQ30217) in canine myocardium.
Stewart, R.E., Hutchins, G.D., Brown, D., McClanahan, T.B., Gallagher, K.D., Petry, N.A., Schwaiger, M., American College of Cardiology 38th Annual Meeting, Anaheim, CA, 1/19/1989
Myocardial retention and clearance of the flow tracer Tc-99m SQ30217 in canine heart.
Stewart, R.E., Hutchins, G.D., Brown, D., McClanahan, T.B., Gallagher, K.D., Petry, N.A., Schwaiger, M., J. Nucl. Med., The Society of Nuclear Medicine 36th Annual Meeting, St. Louis, MO, 1/13/1989
A model for outcome-prediction following stroke using the comparison of CT and HM-PAO SPECT.
Mountz J.M., Modell, J.G., Foster N.L., DuPree E.S., Ackermann R.J., Petry N.A., Kuhl D.E., J. Nucl. Med., The Society of Nuclear Medicine 36th Annual Meeting, St. Louis, MO, 1/13/1989
How accurate and useful is NP-59 scintigraphy in the diagnosis of adrenal disease.
Kazerooni, E., Shapiro, B., Gross, M., Petry, N., Sisson, J., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Clinical experience with Tc-99m anti-melanoma fragments and SPECT.
Wahl, R.L., Johnson, J., Mallette, S., Natale, R., Petry, N.A., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Technical considerations for the preparation and quality control of Tc-99m-HM-PAO for assessment of cerebral blood flow.
Petry, N.A., Ackermann, R.J., Mountz, J.M., Kuhl, D.E., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Stroke prognosis using Tc-99m-HM-PAO SPECT.
Mountz, J.M., Stafford-Schuck, K.A., Foster, N.L., Ackermann, R.J., Petry, N.A., Kuhl, D.E., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Optimizing radioimmunoscinti-graphy with Tc-99m labeled anti-melanoma antibodies.
Johnson, J.W., Mallette, S., Petry, N.A., Wahl, R.L., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Technical considerations for Tc-99m-HM-PAO brain imaging.
Ackermann, R.J., Mountz, J.M., Botti, J.M., Petry, N.A., Kuhl, D.E., J. Nucl. Med. Tech., The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, CA, 1/14/1988
Preparation, quality control and clinical evaluation of Tc-99m-HM-PAO in stroke.
Petry, N.A., Ackermann, R.J., Mountz, J.M., Kuhl, D.E., American Pharmacists Association Annual Meeting, Atlanta, GA, 1/14/1988
Platelet reactivity in human aortic grafts: A prospective randomized study of platelet adherence and release products in dacron and ePTFE conduits.
Wakefield, T.W., Shulkin, B.L., Fellows, E.P., Petry, N.A., Spaulding, S.A., Stanley, J.C., Society for Vascular Surgery/International Society for Cardiovascular Surgery (North American Chapter), Joint Annual Meeting, Chicago, IL, 1/13/1988
Utility of Tc-99m-HM-PAO in evaluation of stroke.
Mountz, J.M., Foster, N.L., Ackermann, R.J., Petry, N.A., Kuhl, D.E., The Radiological Society of North America Annual Meeting, Chicago, IL, 1/29/1987
Leukocyte mediated cardiopulmonary responses secondary to protamine-heparin interaction.
Wakefield, T.W., Kresowik, T.F., Bouffard, J.A., Till, G.O., Petry, N.A., Stanley, J.C., Association for Academic Surgery Annual Meeting, Orlando, FL, 1/2/1987
Occult Choriocarcinoma: Detection using radiolabeled monoclonal antibodies.
Wahl, R.L., Liebert, M., Petry, N.A., et al, Radiology, The Radiological Society of North America Annual Meeting, Chicago, IL, 1/30/1986
Antibodies, Albumin and Antimony: A comparison of three lymphoscintigraphic agents.
Wahl, R.L., Fisher, S., Petry, N.A., Radiology, The Radiological Society of North America Annual Meeting, Chicago, IL, 1/30/1986
Scintigraphic characterization of drug induced alterations in platelet kinetics.
Petry, N.A., Spaulding, S., Bouffard, A., Gross, M.D., Lindblad, B., Wakefield, T.W., Stanley, J., American Pharmacists Association Annual Meeting, San Francisco, CA, 1/16/1986
Nuclide imaging with indium excess ratio and technetium subtraction techniques in assessment of ePTFE graft-platelet interaction.
Wakefield, T., Lindblad, B., Graham, L., Whitehouse, W., Ripley, S., Petry, N., Spaulding, S., Burkel, W. and Stanley, J., Association for Academic Surgery, 1/13/1985
Join now to see all

Lectures

"Radiopharmacy and Radiopharmaceuticals for Theranostic Applications - New 68Ga and 177Lu Radiopharmaceuticals"
Sydney, NSW, Australia - 1/1/2016
"Radiopharmacy PET Drug Development - Untapped Potential of the 68Ge/68Ga Generator"
Durham, NC - 1/1/2015
"The Role of Radiopharmacy Service in Radium-223 Dichloride Therapy"
Durham, NC - 1/1/2013
"Regulatory Considerations in Nuclear Pharmacy Practice"
Baltimore, MD - 1/1/2012
"Radiopharmacy and Radiochemistry for Nuclear Medicine"
Hong Kong, SAR, China - 1/1/2011
"Update on USP <797> and <823> and Their Impact on PET and Nuclear Medicine and Nuclear Pharmacy Practice"
Orlando, FL - 1/1/2011
"A Review of PET Isotopes & Compounds and Their Use in Nuclear Medicine Research and Clinical Practice."
Orlando, FL - 1/1/2011
"Creating a GMP Radiopharmacy in the USA, and Standards for Operational Compliance"
London, England - 1/1/2010
"Facility Design for Full-Scale Nuclear Pharmacy Operation in a Hospital Setting."
Toronto, Canada - 1/1/2009
"Creating a USP <797> Compliant Radiopharmacy and Standards for Operational Compliance."
Salt Lake City, UT - 1/1/2009
"USP General Chapter <797>: Overview and Impact on Nuclear Medicine Technology."
Toronto, Canada - 1/1/2009
"Novel Radiopharmaceuticals: Hurdles and Difficulties in Moving from Test Tube to Human Use."
Toronto, Canada - 1/1/2009
"USP <797> in Nuclear Pharmacy and Nuclear Medicine - Personnel and Facility Requirements."
Newport Beach, CA - 1/1/2008
"USP <797> in Nuclear Pharmacy Practice - Personnel and Facility Requirements."
Orlando, FL - 1/1/2008
"USP <797> in Nuclear Medicine Practice - Personnel and Facility Requirements."
Niagara Falls, NY - 1/1/2008
"Update on USP Chapter <797> and Implications for Nuclear Pharmacy."
Orlando, FL - 1/1/2007
"Nuclear Pharmacy Practice Regulatory Update: USP Chapter <797> Compliance."
San Francisco, CA - 1/1/2006
"Hospital Nuclear Pharmacy Practice - Historical and Future Perspectives"
West Lafayette, IN - 1/1/2005
"Fludeoxyglucose F 18 (FDG): Clinical Development, Production and Distribution."
Orlando, FL - 1/1/2003
"FDG-PET Imaging: Clinical Utility, Pitfalls and Artifacts."
Orlando, FL - 1/1/2003
"Clinical Advances in Nuclear Medicine: PET and Non-Hodgkin's Lymphoma"
Tyler, TX - 1/1/2002
"Treating Malignant Gliomas with Radiolabeled Anti-Tenascin Monoclonal Antibody 81C6"
Albuquerque, NM - 1/1/2002
"Oncology: Applications for Nuclear Medicine"
Charlotte, NC - 1/1/2002
"The Current and Future Role of Radioimmunotherapy in Non-Hodgkin's Lymphoma."
Greensboro, NC - 1/1/2001
"Oncology Applications for Nuclear Medicine"
Charlotte, NC - 1/1/2000
Join now to see all

Other

The selection, use, calibration, and quality assurance of radionuclide calibrators used in nuclear medicine.
Carey J.E., Byrne P., DeWerd L., Lieto R. and Petry N.A., AAPM Report No. 181, Report of AAPM Task Group 181, American Association of Physicists in Medicine
1/1/2012
"USP Chapter <797> Pharmaceutical Compounding - Sterile Preparations Potential Impact on Handling Radiopharmaceuticals."
Cooper J.F. and Petry N.A., Volume 13, Lesson 6; Correspondence Continuing Education Courses for Nuclear Pharmacists and Nuclear
Albuquerque, NM - 1/1/2007

External Links

Neil A. Petry, M.S., RPh, BCNP, FAPhAhttps://radiology.duke.edu/faculty/neil-petry-ms-bs/
Neil Petryhttps://www.researchgate.net/profile/Neil_Petry

Office
40 Duke Medicine Circle
Duke University Medical Center
Durham, NC 27710
Phone+1 919-684-3773

Fax+1 919-684-1230